Renal relevant radiology: Radiologic imaging in autosomal dominant polycystic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 2, 2014, Pages 406-415

  Rahbari Oskoui, Frederic ^a   Mittal, Ankush ^a   Mittal, Pardeep ^a   Chapman, Arlene ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; DIAGNOSTIC IMAGING; FEMALE; HUMANS; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84893547176     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08940813     Document Type: Article

References (55)

1. Gabow PA: Autosomal dominant polycystic kidney disease. N Engl J Med 329: 332-342, 1993
2. Hateboer N, Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D: Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 353: 103-107, 1999
3. Rahbari-Oskoui F, Taylor AP, O'Neill WC: Ultrasonography and nuclear medicine. In: Schrier'sDiseases of the Kidney, Vol. 1, 9th Ed., edited by Schrier RW, Philadelphia, Lippincott Williams & Wilkins, 2012
4. Reed B, Nobakht E, Dadgar S, Bekheirnia MR, Masoumi A, Belibi F, Yan XD, Cadnapaphornchai M, Schrier RW: Renal ultrasonographic evaluation in children at risk of autosomal dominant polycystic kidney disease. AmJ KidneyDis 56: 50-56, 2010
5. Levine E, Hartman DS, Meilstrup JW, Van Slyke MA, Edgar KA, Barth JC: Current concepts and controversies in imaging of renal cystic diseases. Urol Clin North Am 24: 523-543, 1997
6. Rizk D, Chapman AB: Cystic and inherited kidney diseases. Am J Kidney Dis 42: 1305-1317, 2003
7. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343: 824-827, 1994
8. Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D: Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 20: 205-212, 2009
9. Barua M, Pei Y: Diagnosis of autosomal-dominant polycystic kidney disease: An integrated approach. Semin Nephrol 30: 356-365, 2010
10. Chapman AB: Autosomal dominant polycystic kidney disease: Time for a change? J Am Soc Nephrol 18: 1399-1407, 2007
11. O'Neill WC: Atlas of Renal Ultrasonography, Decatur, GA, Saunders, 2006
12. Miletić D, Fuckar Z, Sustić A, Mozetic V, Stimac D, Zauhar G: Sonographic measurement of absolute and relative renal length in adults. J Clin Ultrasound 26: 185-189, 1998
13. Nascimento AB, Mitchell DG, Zhang XM, Kamishima T, Parker L, Holland GA: Rapid MR imaging detection of renal cysts: Agebased standards. Radiology 221: 628-632, 2001
14. IsraelGM, Bosniak MA:MRimaging of cystic renal masses. Magn Reson Imaging Clin N Am 12: 403-412, 2004
15. Laucks SP Jr., McLachlan MS: Aging and simple cysts of the kidney. Br J Radiol 54: 12-14, 1981
16. Tada S, Yamagishi J, KobayashiH, Hata Y, Kobari T: The incidence of simple renal cyst by computed tomography. Clin Radiol 34: 437-439, 1983
17. Carrim ZI, Murchison JT: The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol 58: 626-629, 2003
18. MartinDR, BrownMA, Semelka RC: Primer onMRImaging of the Abdomen and Pelvis, Hoboken, NJ, John Wiley & Sons, 2005
19. Bisceglia M, Galliani CA, Senger C, Stallone C, Sessa A: Renal cystic diseases: A review. Adv Anat Pathol 13: 26-56, 2006
20. Gabow PA, Duley I, Johnson AM: Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis 20: 140-143, 1992
21. Ubara Y, Katori H, Tagami T, Tanaka S, Yokota M, Matsushita Y, Takemoto F, Imai T, Inoue S, Kuzuhara K, Hara S, Yamada A: Transcatheter renal arterial embolization therapy on a patient with polycystic kidney disease on hemodialysis. AmJ Kidney Dis 34: 926-931, 1999
22. Chapman AB, Rahbari-Oskoui F: Therapy in nephrology and hypertension. In: Renal Cystic Disorders, 3rd Ed. Philadelphia, Saunders, 2008
23. Bleeker-Rovers CP, de Sévaux RG, van HamersveltHW, Corstens FH, Oyen WJ: Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis 41: E18-E21, 2003
24. 18F-fluorodeoxyglucose PET/CT in polycystic kidney disease. Ann Nucl Med 22: 529-531, 2008
25. Keith DS, Torres VE, King BF, Zincki H, Farrow GM: Renal cell carcinoma in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 4: 1661-1669, 1994
26. Israel GM, Bosniak MA: How do I do it: evaluating renal masses. Radiology 236: 441-450, 2005
27. Bosniak MA: The current radiological approach to renal cysts. Radiology 158: 1-10, 1986
28. Pedrosa I, Sun MR, Spencer M, Genega EM, Olumi AF, Dewolf WC, Rofsky NM: MR imaging of renal masses: Correlation with findings at surgery and pathologic analysis. Radiographics 28: 985-1003, 2008
29. Martin DR, Krishnamoorthy SK, Kalb B, Salman KN, Sharma P, Carew JD, Martin PA, Chapman AB, Ray GL, Larsen CP, Pearson TC: Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols. J Magn Reson Imaging 31: 440-446, 2010
30. Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, Thomsen HS: Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J AmSoc Nephrol 17: 2359-2362, 2006
31. Chrysochou C, Power A, Shurrab AE, Husain S, Moser S, Lay J, Salama AD, Kalra PA: Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging. Clin J Am Soc Nephrol 5: 484-489, 2010
32. Ziessman HA, O'Malley JP, Thrall JH: Nuclear Medicine-the Requisites, 3rd Ed., edited by ZiessmanHA, Philadelphia, Mosby (Elsevier), 2005
33. Gabow PA, Johnson AM, Kaehny WD, Manco-Johnson ML, Duley IT, Everson GT: Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 11: 1033-1037, 1990
34. Tahvanainen E, Tahvanainen P, Kääriäinen H, Höckerstedt K: Polycystic liver and kidney diseases. Ann Med 37: 546-555, 2005
35. Morgan DE, Lockhart ME, Canon CL, Holcombe MP, Bynon JS: Polycystic liver disease: Multimodality imaging for complications and transplant evaluation. Radiographics 26: 1655-1668, 2006
36. Caroli J: Diseases of the intrahepatic biliary tree. Clin Gastroenterol 2: 147-161, 1973
37. Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF Jr., Wetzel LH, Kenney PJ, Brummer ME, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP): Magnetic resonance imaging evaluation of hepatic cysts in early autosomaldominant polycystic kidney disease: The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin J Am Soc Nephrol 1: 64-69, 2006
38. EversonGT: Polycystic liver disease. Gastroenterol Hepatol (NY) 4: 179-181, 2008
39. Hossack KF, Leddy CL, Johnson AM, Schrier RW, Gabow PA: Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med 319: 907-912, 1988
40. PerroneRD, Abebe KZ, Schrier RW, Chapman AB, Torres VE, Bost J, Kaya D, Miskulin DC, Steinman TI, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin D, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Bae KT, Meyers CM; HALT PKD Study Group: Cardiac magnetic resonance assessment of left ventricularmass in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6: 2508-2515, 2011
41. Yaqoob M, Saffman C, Finn R, Carty AT: Inferior vena caval compression by hepatic cysts: An unusual complication of adult polycystic kidney disease. Nephron 54: 89-91, 1990
42. Torres VE, Rastogi S, King BF, StansonAW, Gross JB Jr., NogorneyDM: Hepatic venous outflow obstruction in autosomal dominant polycystic kidney disease. J AmSoc Nephrol 5: 1186-1192, 1994
43. Iguchi S, Kasai A, KishimotoH, Suzuki K, Ito S, Ogawa Y, Nishi S, Gejyo F, Ohno Y: Thrombosis in inferior vena cava (IVC) due to intra-cystic hemorrhage into a hepatic local cyst with autosomal dominant polycystic kidney disease (ADPKD). Intern Med 43: 209-212, 2004
44. Maeda T, Uchida Y, Oyamada K, Nakajima F: Thrombosis in inferior vena cava due to enlarged renal cysts in autosomal dominant polycystic kidney disease. InternMed 49: 1891-1894, 2010
45. O'Sullivan DA, Torres VE, Heit JA, Liggett S, King BF: Compression of the inferior vena cava by right renal cysts: An unusual cause of IVC and/or iliofemoral thrombosis with pulmonary embolismin autosomal dominant polycystic kidney disease. Clin Nephrol 49: 332-334, 1998
46. Vlak MH, Algra A, Brandenburg R, Rinkel GJ: Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: A systematic review and meta-analysis. Lancet Neurol 10: 626-636, 2011
47. Gibbs GF, Huston J 3rd, Qian Q, Kubly V, Harris PC, Brown RD Jr., Torres VE: Follow-up of intracranial aneurysms in autosomaldominant polycystic kidney disease. Kidney Int 65: 1621-1627, 2004
48. IrazabalMV, Huston J 3rd, Kubly V, Rossetti S, Sundsbak JL, Hogan MC, Harris PC, Brown RD Jr., Torres VE: Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6: 1274-1285, 2011
49. Chapman AB, S S: Autosomal dominant polycystic kidney disease. In: Schrier's Diseases of theKidney, Vol. 1, 9th Ed., edited by Schrier RW, Philadelphia, LippincottWilliams &Wilkins, 2013
50. Schrier RW, Belz MM, Johnson AM, Kaehny WD, Hughes RL, Rubinstein D, Gabow PA: Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: A prospective ten-year follow-up. J Am Soc Nephrol 15: 1023-1028, 2004
51. Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr., Glockner JF, Wetzel LH, Brummer ME, O'Neill WC, Robbin ML, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort: Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int 64: 1035-1045, 2003
52. Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D, Li J, King BF, Martin D, Wetzel LH, Lockhart ME, Harris PC, Moxey-Mims M, Flessner M, Bennett WM, Grantham JJ: Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 7: 479-486, 2012
53. Harris PC, Bae KT, Rossetti S, Torres VE, Grantham JJ, Chapman AB, Guay-Woodford LM, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Consugar M, Klahr S, Bennett WM, Meyers CM, Zhang QJ, Thompson PA, Zhu F, Miller JP: Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 17: 3013-3019, 2006
54. King BF, Torres VE, BrummerME, Chapman AB, Bae KT, Glockner JF, Arya K, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP): Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomaldominant polycystic kidney disease. Kidney Int 64: 2214-2221, 2003
55. Pei Y: Practical genetics for autosomal dominant polycystic kidney disease. Nephron Clin Pract 118: c19-c30, 2011